Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm Smith

Showing results (181-190 of 188) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 188 results.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2020
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew D J Pearson, C Michel Zwaan, E Anders Kolb, et al.
European Journal of Cancer (Oxford, England : 1990)|January 28, 2020
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patientsAndrew D J Pearson, Claudia Rossig, Giovanni Lesa, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trialCraig Mowat, Ian Arnott, Aiden Cahill, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2022
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Nathalie Gaspar, Katherine Janeway, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2025
Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Sabine Mueller, Mariella G Filbin, et al.
Cancer Cell|August 18, 2012
Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemiaKathryn G Roberts, Ryan D Morin, Jinghui Zhang, et al.
Nature Genetics|July 12, 2011
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibilityDavid M Evans, Chris C A Spencer, Jennifer J Pointon, et al.
Journal of Orthopaedic Trauma|May 1, 2013
Scapula fractures: interobserver reliability of classification and treatmentValentin Neuhaus, Arjan G J Bot, Thierry G Guitton, et al.
Pageof 19

Showing results (181-190 of 188) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 188 results.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2020
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew D J Pearson, C Michel Zwaan, E Anders Kolb, et al.
European Journal of Cancer (Oxford, England : 1990)|January 28, 2020
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patientsAndrew D J Pearson, Claudia Rossig, Giovanni Lesa, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trialCraig Mowat, Ian Arnott, Aiden Cahill, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2022
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Nathalie Gaspar, Katherine Janeway, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2025
Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Sabine Mueller, Mariella G Filbin, et al.
Cancer Cell|August 18, 2012
Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemiaKathryn G Roberts, Ryan D Morin, Jinghui Zhang, et al.
Nature Genetics|July 12, 2011
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibilityDavid M Evans, Chris C A Spencer, Jennifer J Pointon, et al.
Journal of Orthopaedic Trauma|May 1, 2013
Scapula fractures: interobserver reliability of classification and treatmentValentin Neuhaus, Arjan G J Bot, Thierry G Guitton, et al.
Pageof 19